Second Trimester Abortion Clinical Trial
Official title:
Pharmacological Inhibition of Lactation After 16 to 20 Week Abortion: a Randomized Controlled Trial
The goal of this clinical trial is to compare breast symptoms (lactation, engorgement, etc) of individuals who undergo a procedure for second trimester of pregnancy loss between 16 weeks and 20 weeks gestational age. The participants will be randomly placed in two groups, one with a placebo tablet and one with medication called "cabergoline" which are taken immediately after their procedure. Researchers will compare groups to see if there are any significant differences in breast symptoms.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04063904 -
Pilot Study of an Ambulatory Medical Abortion Service at 13-18 Weeks of Gestation in Colombia
|
Phase 4 | |
| Completed |
NCT03400358 -
Uterocervical Angle in the Pregnancy Termination of Multiparous Women
|
N/A | |
| Recruiting |
NCT04501809 -
Second Trimester Pregnancy Termination in Women With Previous Caesarean Sections
|
N/A | |
| Recruiting |
NCT03044093 -
Mifepristone and Misoprostol Compared With Misoprostol Alone for Second Trimester Abortion
|
Phase 4 | |
| Enrolling by invitation |
NCT06078501 -
MisOpRostol Effect on Second Trimester Abortion Blood Loss
|
Phase 3 | |
| Completed |
NCT04181541 -
Midlevel Versus Physician-provided Medical Abortion in the Second Trimester
|
N/A | |
| Completed |
NCT06164067 -
The Role of Cervical Consistency Index and Uterocervical Angles in Medical Termination
|
||
| Completed |
NCT02033083 -
Laminaria Compared to Dilapan-S for Cervical Preparation Before Dilation and Evacuation at 18-24 Weeks of Gestation
|
N/A | |
| Terminated |
NCT03714880 -
Cervical Preparation With Mifepristone Prior to Osmotic Dilators
|
Phase 2 | |
| Completed |
NCT03407521 -
Misoprosotol and Isosorbide Mononitrate for Induction of Second Trimester Abortion
|
Phase 4 |